The 2nd CRISPR Medicine Conference 2025, April 7-11, Copenhagen, Denmark
Important Dates for the 2nd CRISPR Medicine Conference 2025
Before the Event:
July 1st 2024: Registration & abstract submissions open
January 3rd 2025: Early bird registration deadline
January 17th 2025: Abstract submission deadline
February 28th 2025: Oral and poster notifications & final programme available
March 3rd 2025: Travel grant notification
April 4th 2025: Registration deadline in-person event
April 4th 2025: Registration deadline virtual event
April 7th 2025: Abstract publication in the CRISPR Medicine News portal
Events:
Scientific Conference Virtual Event: April 7th 2025 (15:00 - 18:00 PM CEST)
Scientific Conference In-person Event: April 8th - 11th 2025, Copenhagen, Denmark (Opening Session April 8th, 14:00 PM CEST, Closing Address, April 11th, 13:00 PM CEST)
Founders Breakfast: April 8th 2025, Copenhagen, Denmark (9:00 - 13:00 PM CEST) "Invest in Future CRISPR Medicine | Develop Future Medicine" | B2B networking | Investors and early-phase startups
Welcome
The 2nd CRISPR Medicine Conference (in-person) will take place in Copenhagen, Denmark from the 8th - 11th April 2025 (virtual event 7th April).
This event will bring the global CRISPR Medicine community to the forefront, with focus on the most critical topics in the therapeutic gene-editing field: Tools, Delivery, Safety, Functional Genomics, Standards and Regulations, Pre-clinical Research and Clinical Trials.
The Scientific Conference will include both a virtual event and an in-person event and will include talks by reputable speakers from academia and industry, as well as several workshops focused on developing useful skills for a successful career in gene editing.
New for CRISPRMED25: A unique Startup-Investor event, Founders Breakfast, will take place at the conference venue on Tuesday morning 8th April 2025 (before the Scientific Conference begins). Selected founders from CRISPR startups and investors will present at this event, followed by 1:1 meetings. If you are an investor or part of an early-stage startup and would like to attend this meeting and/or the Scientific Conference, please register to attend here.
You can register to attend the event and submit an abstract directly through this website. Our separate in-person and virtual poster sessions will allow any type of attendee to present and discuss their research with their peers.
Attendees who submit the top-scoring abstracts will be invited to present their work in an oral presentation and selected delegates will be interviewed by CRISPR Medicine News, which boasts an audience of over 25,000 readers per month.
Once you have registered, you will be able to explore the content and see the list of participants.
Meet the confirmed CRISPRMED25 attendees here.
If you have any questions, please refer to our FAQ section or contact CRISPRMED25 staff at info@crisprmedicineconference.com.
**CRISPRMED25 Newsletter - Sign up here**
The Preliminary Programme is now available
Keynote Speaker
Virginijus Šikšnys PhD
Vilnius University Life Sciences Centre, Lithuania
Virginijus Šikšnys holds a chair of distinguished professor at Vilnius University and serves as chairman of the board of Life Science Center of Vilnius University. His groundbreaking research on CRISPR-Cas has had a major impact on the gene-editing field, paving the way for the development of novel tools for genome-editing applications.
Virginijus studied chemistry at Vilnius University and obtained his Ph.D. from Moscow State University before returning to Vilnius where he moved through different research ranks at the Institute of Applied Enzymology/ Institute of Biotechnology. In 1994 he stayed as a visiting scientist in the lab of Prof. Robert Huber at Max Planck Institute of Biochemistry in Germany.
Virginijus is a member of Academia Europaea, EMBO, Lithuania Academy of Sciences and Norwegian Academy of Sciences and Letters. His work has been recently recognised with numerous awards and prizes including the Kavli Prize.
See the detailed confirmed speaker list here.
Patient Advocate
Jimi Olaghere
At CRISPRMED25, Jimi will share his story about living with sickle cell disease, before and after treatment with the recently approved CRISPR therapy CASGEVY.
Sponsors and Supporters
Scientific Committee
Alessia Cavazza, Ass. Prof., Group Leader, University College London's Great Ormond Street Institute of Child Health, England
Anna Cereseto, Prof., Vice-Director, Centre for Integrative Biology (CIBIO), University of Trento, Italy
Karim Benabdel Lah El Khlanji, Senior Scientist at the GENyO Pfizer-University of Granada-Junta de Andalucia Center for Genomics and Oncological Research in Granada, Spain, GeneHumdi Action Chair
Rasmus O. Bak, Tenured Associate Professor at the Department of Biomedicine at Aarhus University, Co-founder of UNIKUM Therapeutics, Denmark
Marcello Maresca, Senior Director, Genome Engineering Team, AstraZeneca, Sweden
Ayal Hendel, Principal Investigator at The Mina and Everard Goodman Faculty of Life Sciences at Bar-Ilan University, Israel
Karen O´Hanlon Cohrt, Chief Editor CRISPR Medicine News, CMN
Organising Committee
Karen O´Hanlon Cohrt, Chief Editor, CRISPR Medicine News
Gorm Palmgren, Science Writer and Editor, CRISPR Medicine News
Antonio Carusillo, Science Writer, CRISPR Medicine News
Manel Lladó, Science Writer, CRISPR Medicine News
Jens-Ole Bock, Founder, CRISPR Medicine News / CRISPRMED
Location
Copenhagen, Denmark
Registration period
June 30, 2024 - 0:00 until April 4, 2025 - 23:59
Submission period
June 30, 2024 - 0:00 until January 17, 2025 - 23:59
Contact us
If you have any questions, please contact info@crisprmedicineconference.com .